The DOI matches its Crossref record; 252 of the 252 references it cites were found in a registry or an index.
NO as a signalling molecule in the nervous system
Open accessAbstract
The discovery that nitric oxide (NO) functions as a signalling molecule in the nervous system has radically changed the concept of neural communication. Indeed, the adoption of the term nitrergic for nerves whose transmitter function depends on the release of NO or for transmission mechanisms brought about by NO (Moncada et al., 1997) emphasizes the specific characteristics of this mediator. The physical properties of NO prevent its storage in lipid-lined vesicles and metabolism by hydrolytic degradatory enzymes. Therefore, unlike established neurotransmitters, NO is synthesized on demand and is neither stored in synaptic vesicles nor released by exocytosis, but simply diffuses from nerve terminals. The distance of this NO diffusion (40 – 300 μm in diameter) implies that structures in the vicinity of the producing cell, both neuronal and non-neuronal, are influenced following its release. This suggests that, as well as acting as a neurotransmitter, NO has a neuromodulatory role (Garthwaite & Boulton, 1995). In addition, it diffuses into rather than binds with protein receptors on adjacent cells, and most of its known actions are the consequence of interplay with intracellular targets that would usually be regarded as secondary messengers. The activity of conventional neurotransmitters is terminated either by re-uptake mechanisms or enzymatic degradation while inactivation of NO follows reaction with a substrate. There are multiple points at which biological control can be exerted over the production and activity of conventional neurotransmitters. However, control of the synthesis of NO is the key to regulating its activity. Endothelial NOS (eNOS) and inducible NOS (iNOS) are present in the nervous system and will be duly addressed here. However, neuronal NOS (nNOS) is the principal isoform present in said system and will be the main focus of this review. All nNOS positive neurones exhibit α-nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase activity, which has become the histochemical marker of nitrergic neurones. However, early results demonstrating this may have been limited by inappropriate fixation procedures and should be viewed with caution (Wolf, 1997). The original cloning of full-length nNOS produced what is now designated as nNOSα, and which accounts for the majority of nNOS activity in nervous tissue (Bredt et al., 1991). In addition, four splice variants have recently been identified (nNOSβ, nNOSγ, nNOSμ and nNOS-2) and these appear to exhibit distinct cellular and tissue locations (Gibson, 2001; Nakane et al., 1993; Silvagno et al., 1996; Alderton et al., 2001). In particular, there is growing evidence that nNOS biosynthesis in excitable tissues is not restricted to neurones while substantial amounts of this enzyme have been identified in skeletal muscle, where it is involved in the regulation of metabolism and muscle contractility (Stamler & Meissner, 2001). The magnitude of literature dealing with the role of NO in the nervous system is so great that it would be impossible to include in this review the entirety of the research carried out. For logistical reasons, only groundbreaking references have been quoted, but when necessary, recent reviews dealing with specific areas within the field have been included and are intended to act as a guideline for further reading. The most important regulator of nNOS activity seems to be free cytosolic Ca2+, which stimulates nNOS through interaction with calmodulin. Arrival of action potentials activates voltage-dependent Ca2+ channels situated in the neurolemma, and stimulates the release of Ca2+ from intracellular stores. This elevates cytosolic Ca2+ concentrations above the 400 nM required for calmodulin to bind to nNOS, thereby activating the enzyme. When the concentration of Ca2+ falls, it dissociates from the calmodulin, which in turn dissociates from the nNOS, thus acting as a switch that turns the enzyme on and off (Knowles et al., 1989; Sheng et al., 1992). Phosphorylation, although less well analysed, constitutes an additional mechanism for regulating nNOS activity. The catalytic activity of the enzyme is decreased following phosphorylation by cyclic adenosin monophosphate (cyclic AMP)-dependent protein kinase (Bredt et al., 1992; Brüne & Lapetina, 1991), protein kinase C (Bredt et al., 1992; Nakane et al., 1991) or Ca2+/calmodulin-dependent protein kinase II (Bredt et al., 1992; Hayashi et al., 1999; Komeima et al., 2000; Nakane et al., 1991; Schmidt et al., 1992b). This process occurs in the majority of peripheral and in some central nitrergic neurones (Figures 1 and 2). However, in the CNS, NO synthesis seems predominantly regulated by the influx of Ca2+ through receptor-dependent channels, in particular following postsynaptic stimulation of NMDA receptors by the excitatory neurotransmitter, glutamate (Bredt & Snyder, 1989; Garthwaite et al., 1989). The amino acid terminal of nNOS possesses a PDZ domain which is not present in the
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–252 of 252
Role of Nitric Oxide in Central Synaptic Transmission: Effects on Neurotransmitter Release
Kuriyama, K., & Ohkuma, S. (1995) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.69.1 · Cited by 87
Hobbs, A. J., Tucker, J. F., & Gibson, A. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12483.x · Cited by 85
Evidence that nitric oxide modulates drinking behaviour
Calapai, G., Squadrito, F., Altavilla, D., Zingarelli, B., Campo, G. M., Cilia, M., & Caputi, A. P. (1992) · Neuropharmacology · doi:10.1016/0028-3908(92)90038-q · Cited by 85
Nitric oxide and nitric oxide synthase in Huntington's disease
Deckel, A. W. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1057 · Cited by 83
NMDA receptors increase OH radicals in vivo by using nitric oxide synthase and protein kinase C
Hammer, B., Parker, W. D., & Bennett, J. P. (1993) · Neuroreport · doi:10.1097/00001756-199310000-00018 · Cited by 83
Steel, J. H., Terenghi, G., Chung, J. M., Na, H. S., Carlton, S. M., & Polak, J. M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90361-1 · Cited by 82
Martin, W., McAllister, K. H. M., & Paisley, K. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90029-9 · Cited by 81
The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat
Stagliano, N. E., Dietrich, W. D., Prado, R., Green, E. J., & Busto, R. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00200-x · Cited by 81
Marks, K. A., Mallard, C. E., Roberts, I., Williams, C. E., Gluckman, P. D., & Edwards, A. D. (1996) · Pediatric Research · doi:10.1203/00006450-199608000-00002 · Cited by 79
Role of nitric oxide in modulating neurotransmitter release from rat striatum
Sandor, N. T., Brassai, A., Pliskas, A., & Lendvai, B. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00229-t · Cited by 78
Iadecola, C., Zhang, F., & Xu, X. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.4.r738 · Cited by 77
Weinberger, B. I., Heck, D. E., Laskin, D. L., & Laskin, J. D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00044-3 · Cited by 75
Cellek, S., & Moncada, S. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702278 · Cited by 75
Sheng, H., Schmidt, H. H. H. W., Nakane, M., Mitchell, J. A., Pollock, J. S., Föstermann, U., & Murad, F. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14411.x · Cited by 73
Modulation by nitric oxide of metalloprotein regulatory activities
Drapier, J., & Bouton, C. (1996) · BioEssays · doi:10.1002/bies.950180706 · Cited by 71
Aguila, M. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.782 · Cited by 71
Nitric oxide and nitric oxide synthase: biology, pathology, localization.
Wolf, G. L. (1997) · PubMed · Cited by 68
Barrachina, M. D., Panes, B. S. P. J., & Esplugues, B. S. P. J. V. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398491 · Cited by 67
Shah, S., Nathan, L., Singh, R., Fu, Y. S., & Chaudhuri, G. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.5.r1546 · Cited by 65
Nitric oxide theory of migraine.
Thomsen, L. L., & Olesen, J. (1998) · PubMed · Cited by 63
Neuroprotection against nitric oxide injury with inhibitors of ADP-ribosylation.
Wallis, R. A., Panizzon, K. L., Henry, D., & Wasterlain, C. G. (1993) · PubMed · Cited by 62
Binding of Dynein Light Chain (PIN) to Neuronal Nitric Oxide Synthase in the Absence of Inhibition
Rodríguez‐Crespo, I., Straub, W., Gavilanes, F., & de Montellano, P. R. O. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0928 · Cited by 62
The effect of lactation on nitric oxide synthase gene expression
Ceccatelli, S., & Eriksson, M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90153-e · Cited by 62
Role of nitric oxide as an inhibitory neurotransmitter in the canine pyloric sphincter.
Bayguinov, O., & Sanders, K. (1993) · American Journal of Physiology · doi:10.1152/ajpgi.1993.264.5.g975 · Cited by 62
Lithium and Tacrine Increase the Expression of Nitric Oxide Synthase mRNA in the Hippocampus of Rat
Bagetta, G., Corasaniti, M. T., Melino, G., Paoletti, A. M., Finazzi‐Agrò, A., & Nisticò, G. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2595 · Cited by 60
Reduction of striatal N-methyl-d-aspartate toxicity by inhibition of nitric oxide synthase
Kollegger, H., McBean, G. J., & Tipton, K. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90401-h · Cited by 59
Minami, T., Nishihara, I., Ito, S., Sakamoto, K., Hyodo, M., & Hayaishi, O. (1995) · Pain · doi:10.1016/0304-3959(94)00183-f · Cited by 55
Neuroprotection against nitricf oxide injury with inhibitors of ADP-ribosylation
Wallis, R. A., Panizzon, K. L., Henry, D., & Wasterlain, C. G. (1993) · Neuroreport · doi:10.1097/00001756-199312000-00015 · Cited by 55
Hemmens, B., Woschitz, S., Pitters, E., Klösch, B., Völker, C., Schmidt, K., & Mayer, B. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00704-2 · Cited by 54
Esplugues, J. V., Barrachina, M. D., Beltrán, B., Calatayud, S., Whittle, B. J. R., & Moncada, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14839 · Cited by 52
Self-citationChronic Exposure to Aluminum Impairs Neuronal Glutamate‐Nitric Oxide‐Cyclic GMP Pathway
Cucarella, C., Montoliu, C., Hermenegildo, C., Sáez, R., Manzo, L., Miñana, M., & Felipo, V. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041609.x · Cited by 47
Papka, R. E., McCurdy, J. R., Williams, S. J., Mayer, B., Marson, L., & Platt, K. B. (1995) · The Anatomical Record · doi:10.1002/ar.1092410413 · Cited by 42
Watanabe, A., Ono, M., Shibata, S., & Watanabe, S. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11599-r · Cited by 42
Reiser, G. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15521.x · Cited by 41
Gibson, A., & Mirzazadeh, S. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11863.x · Cited by 41
Melis, M. R., Stancampiano, R., & Argiolas, A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90349-2 · Cited by 40
Photoneural Regulation of Rat Pineal Nitric Oxide Synthase
Schaad, N., Vaněček, J., & Schulz, P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62062496.x · Cited by 40
Opiate withdrawal during development: are NMDA receptors indispensable?
Zhu, H., & Barr, G. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01792-2 · Cited by 40
Immunohistochemical detection of nitrotyrosine in postischemic cerebral cortex in gerbil
Tanaka, K., Shirai, T., Nagata, E., et al. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00725-8 · Cited by 37
Thomas, G. R., & Ramwell, P. W. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91542-8 · Cited by 37
Lesion-induced NADPH-diaphorase reactivity in neocortical pyramidal neurones
Kitchener, P. D., van der Zee, C. E. E. M., & Diamond, J. (1993) · Neuroreport · doi:10.1097/00001756-199305000-00006 · Cited by 37
Regidor, J., Montesdeoca, J., Ramírez-González, J. A., Hernandez-Urquia, C. M., & Divac, I. (1993) · Brain Research · doi:10.1016/0006-8993(93)91206-8 · Cited by 37
Crosby, G., Marota, J. J. A., & Huang, P. L. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00395-y · Cited by 36
Okere, C. O., & Kaba, H. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01325.x · Cited by 32
Boeckxstaens, G. E., Man, J. G. D., Pelckmans, P. A., et al. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13732.x · Cited by 31
Beltrán, B., Barrachina, M. D., Méndez, A., et al. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702717 · Cited by 26
Role of nitric oxide in penile erection and yawning induced by 5-HT1c receptor agonists in male rats
Melis, M. R., Stancampiano, R., & Argiolas, A. (1995) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169086 · Cited by 23
Wilderman, M. J., & Armstead, W. M. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.4.h1807 · Cited by 22
Huh, Y., Heo, K., Park, C., & Ahn, H. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00800-4 · Cited by 21
A cerebral nitrergic pathway modulates endotoxin‐induced changes in gastric motility
Quintana, E., García‐Zaragozá, E., Martínez-Cuesta, M. Á., Calatayud, S., Esplugues, J. V., & Barrachina, M. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704258 · Cited by 20
Self-citationGarcía‐Zaragozá, E., Barrachina, M. D., Moreno, L., & Esplugues, J. V. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703436 · Cited by 18
Self-citationBowman, A., Gillespie, J. S., & Soares-da-Silva, P. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10169.x · Cited by 14
Cited by
Neurobiology and consequences of social isolation stress in animal model—A comprehensive review
Mumtaz, F., Khan, M. I., Zubair, M., & Dehpour, A. R. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.086 · Cited by 369
Oxidative Stress during HIV Infection: Mechanisms and Consequences
Ivanov, A. V., Valuev-Elliston, V. T., Ivanova, O. N., Kochetkov, S. N., Starodubova, E. S., Bartosch, B., & Isaguliants, M. G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8910396 · Cited by 365
Janaszak-Jasiecka, A., Płoska, A., Wierońska, J. M., Dobrucki, L. W., & Kalinowski, L. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00423-2 · Cited by 358
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Mollace, V., Muscoli, C., Masini, E., Cuzzocrea, S., & Salvemini, D. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.1 · Cited by 357
Pain and analgesia: The dual effect of nitric oxide in the nociceptive system
Cury, Y., Picolo, G., Gutierrez, V. P., & Ferreira, S. H. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.06.004 · Cited by 315
Metadata
- Authors
- Esplugues, J. V.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-03
- Volume
- 135
- Issue
- 5
- Pages
- 1079-1095
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2019465027
- Cited by
- 545
- References
- 252
- FWCI
- 9.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.